Impact of Smoking, Benzodiazepine (BZD) Use and Obesity on Severe Obstructive Sleep Apnea (sOSA)
- Conditions
- ObesitySmokingObstructive Sleep Apnea
- Registration Number
- NCT02539264
- Lead Sponsor
- Astes
- Brief Summary
In this study the investigators will analyze the influence of smoking, benzodizepine use, and obesity among patients with severe Obstructive Sleep Apnea (sOSA).
- Detailed Description
This study is a retrospective study. Patients enrolled: all patients with a PSG (polysomnography) between 1st January 2014 and 30th June 2015.
First analysis: influence of smoking, benzodiazepine use, and obesity on the AHI (Apnea Hypopnea Index: the number of apnea and hypopnea per hour of sleep).
Second analysis: only among patients with sOSA: influence of smoking, benzodiazepine use, and obesity on sleep fragmentation and night oximetry.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 920
- All patients registered for an overnight PSG at Clinique Saint-Luc of Bouge
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Apnea Hypopnea Index 1 day Apnea Hypopnea Index (AHI) is defined as the number of apnea and hypopnea per hour of sleep. It is the major determinant of the severity of OSA.
- Secondary Outcome Measures
Name Time Method Sleep fragmentation defined by the percentage of time spent in each of the four stades of sleep (Stade 1, Stade 2, Slow wave sleep and Rapid Eye Movements) 1 day Are smoking and/or obesity a risk factor for sleep fragmentation?
Time spent under 90% of SpO2 during the night 1 day Are smoking and/or obesity a risk factor for oxygen desaturation (\< 90% SpO2) during the night?